Google DeepMind CEO Demis Hassabis says AI could redesign drug discovery, with Isomorphic Labs aiming to cut timelines, ...

Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...

The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is ...

Business leaders must understand what patient-centric care really requires. Too often, patients, researchers and investors ...

Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug ...

If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...

Transfer learning can help biopharmaceutical developers to leverage historical data to guide the development of new manufacturing processes.

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going ...

A collaborative study by the Tufts Center for the Study of Drug Development and CRIO identifies protocol interpretation and ...

Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...

Amazon has already collaborated with Memorial Sloan Kettering Cancer Center with its AI software.